|6. Treat with MTX over NSAIDs (PICO 9)|Very low (67)|
|Conditional recommendation based on very-low-quality evidence; may consider NSAIDs before starting MTX in patients with less active disease, after careful consideration of cardiovascular risks and renal risks of NSAIDs.| |
|7. Treat with an IL-17i biologic over an IL-12/23i biologic (PICO 15)|Very low|